CCR7 and melanoma: In addition, the modulation of the frequency of T cell subpopulations (Figure 1), in particular, activated central memory or effector memory T cells (CCR7+CD45RA− or CCR7−CD45RA−), has been investigated as a correlative biomarker for immune checkpoint infusions in melanoma patients [12,16,17,18,19].